Facility # 1
601 F Street Northwest
Washington, District of Columbia 20004
Washington, District of Columbia 20004
We've found
1 trials
at this facility
Thyroid Cancer Clinical Trial
Updated: 12/31/1969
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
